Advanced Search
Contact | Corporate | Help

A Study of the Safety, Tolerability, Pharmacokinetics, and Bioavailability of IV and SC MABT5102A in Healthy Volunteers

Sponsors:
  • Genentech
Phases:
  • Phase I
IndicationsAcronym:
  • Healthy
Age Groups:
  • Adult
Gender:
Both
Names:
  • Drug: MABT5102A
  • Drug: MABT5102A
Enrollment:
22

Additional information about NCT00997919.


SourceSolution © 2008-2012